Communiqué de Presse IMCAS - PB Communication - Février 2012

Click here to load reader

  • date post

    14-Sep-2014
  • Category

    Lifestyle

  • view

    81
  • download

    0

Embed Size (px)

description

The Press File of the International congress of plastic surgery : IMCAS 2012 (January 26-29 th )

Transcript of Communiqué de Presse IMCAS - PB Communication - Février 2012

  • IMCAS PRESS OFFICE - P.B Communication 7 Villa des Sablons 92200 Neuilly sur Seine - Tel : + 33 1 47 31 11 06 - E-mail : pbcom@wanadoo.fr

    www.imcas.com

    PRESS KIT

    THURSDAY, JANUARY 26th 2012

  • PRESS FILE Paris - January 2012

    IMCAS PRESS OFFICE - P.B Communication 7 Villa des Sablons 92200 Neuilly sur Seine - Tel : + 33 1 47 31 11 06 - E-mail : pbcom@wanadoo.fr

    www.imcas.com

    2

    IMCAS is one of the most important European Courses dedicated to Plastic Surgery and Cosmetic Dermatology. By welcoming more than 3 500 delegates each year during its annual conference, it represents a true "medical population sampling". Its main objective is to promote the highest possible standards in clinical practice, education and research within the plastic surgery / dermatology interface, as well as in related disciplines (facial plastic surgery, oculoplastic surgery, aesthetic medicine, research, etc). It's now an institutional teaching congress, working with advices from several learned societies such as the SOFCEP (Socit Franaise des Chirurgiens Esthticiens Plasticiens), the ESLD (European Society for Laser Dermatology) and the ASDS (American Society for Dermatologic Surgery).

    Benjamin ASCHER, French Board certified Plastic Surgeon and IMCAS Course Director

    The Course Coordinators: David J GOLDBERG, Dermatologist (United States)

    Bernard MOLE, Plastic Surgeon (France) Bernard ROSSI, Dermatologist, (France)

    The Scientific Secretaries:

    Olivier GERBAULT, Plastic Surgeon (France) Anne LE PILLOUER PROST, Dermatologist (France)

    Serge MORDON, PhD Research (France)

    Minutes of the International press conference held on, January 26th PALAIS DES CONGRES Paris

  • PRESS FILE Paris - January 2012

    IMCAS PRESS OFFICE - P.B Communication 7 Villa des Sablons 92200 Neuilly sur Seine - Tel : + 33 1 47 31 11 06 - E-mail : pbcom@wanadoo.fr

    www.imcas.com

    3

    SUMMARY

    Facial and neck rejuvenation New trends Body shaping in 2012

    IMCAS 2012: The cosmeto vigilance watcher IMCAS Industry Tribune: the largest observatory of the aesthetic market The aesthetic market: structure, features and trends: World, Europe and France A focus on the Asian Market: trends and figures

    Laurent BRONES, Business Development Manager, SYMATESE- France

    Current and future trends in lasers and energy based devices in dermatology Moshe LAPIDOTH, Dermatologist - Israel

    Face lifting: fillers or surgery? Neck Lift: focus on non-invasive methods New trends in Botulinum Toxins Hyaluronic Acid: lift, volumize, block : Specific characteristics comparison

    Benjamin ASCHER, Plastic surgeon France PIP crisis : the IMCAS and the French Plastic Surgery position

    Benjamin ASCHER, Plastic surgeon France- Scientific Director of IMCAS congress Olivier GERBAULT, Plastic surgeon- France

    Bernard Mle, Plastic surgeon- France Bruno Alfandari, Plastic surgeon-France

    President of National Union of Plastic, Reconstructive and Aesthetic Acellular dermal matrix (ADM): a revolution in aesthetic surgery

    Olivier GERBAULT, Plastic surgeon France Getting nice buttocks: how to give them volume, to treat sagging and to rejuvenate? Surgical reshaping: volume and downsides Raul GONZALEZ, Plastic surgeon Brazil Cellulite and body shaping: whats hot? David J. GOLDBERG, Dermatologist-USA Lipofilling, whats new? Bernard MOLE, Plastic surgeon- France Fat graft and stem cells: fundamentals & practical applications Ali MOJALLAL, Plastic surgeon- France IMCAS as a talent scout: IMCAS Business Incubator and IMCAS AWARDS

    Serge MORDON, PhD Research, France

    FOR MORE INFO, CLICK ON: LA NUIT DES IMCAS AWARDS

    IMCAS INCUBATORS IMCAS WEB TV Follow IMCAS on Twitter

    Find IMCAS on Facebook

    Join IMCAS on Linked In

  • PRESS FILE Paris - January 2012

    IMCAS PRESS OFFICE - P.B Communication 7 Villa des Sablons 92200 Neuilly sur Seine - Tel : + 33 1 47 31 11 06 - E-mail : pbcom@wanadoo.fr

    www.imcas.com

    4

    IMCAS INDUSTRY TRIBUNE

    The largest observatory of the aesthetic market Benjamin ASCHER, Plastic Surgeon, IMCAS Course Director, FRANCE Laurent BRONES, Business Development Manager, SYMATESE, FRANCE Thierry CHIGNON, Investment Director, MATIGNON INVESTISSEMENT & GESTION, France

    Analysis, prospects and trends of the medical and surgical aesthetic market, 2010-2016

    - Under embargo till January 26th included - IMCAS Industry Tribune 2012, January 27th 2012 The Tribune IMCAS 2012 combines the data available on the medical & surgical aesthetic market, supplied by the Market Studies Societies (MRG & MII NEWS), the financial analysts and the industrial representatives attending the 2012 Tribune, including Allergan, Galderma, Skinceuticals, Syneron, as well as the data from the ISAPS (International Society of Aesthetic and Plastic Surgery) Study on the different procedures practiced over 2010. The IMCAS Tribune thus realised an exhaustive and unseen analysis on the different territories (Europe, USA, Pacific Asia, Latin America) between 2010 and 2016, in US$, covering the most important segments of the market: botulinum toxins, fillers, active cosmetics, lasers and energy devices, breast implants. The variations here observed between the different information sources available bring us to make an evaluation of the different market segments on two hypothesis: one high, one low.

    A bipolar market: a 2-gears growth

    Market facts and key figures By Thierry Chignon & Laurent Brones, co-coordinators of IMCAS Industry Tribune

    The world market1 is evaluated between 3,2 and 3,8 Billions Euros for 2011, i.e. + 10,1% compared to 2010, with an expected growth of +11,2% in 2012, being thus a demonstration of the sector's dynamic state.

    The European financial debt and crisis should impact the European Market in 2012, with a growth estimated up to +5% between 2012 and 2011. According to our high and low estimations, the European market should be in the range of 770 940 Billions euros to grow in 2012 to 808 985 Billions Euros.

    Beyond 2012 and depending of the European Financial crisis evolution, the Tribune estimates the average annual European growth between 2012 and 2016 to be up to + 7% (10 to 12% on the other territories.)

    Asia will know the stronger growth up until 2016, and will reach the European market standards to 1,1 1,3 Billions Euros with an average annual growth of 15,7%, against 7% only for Europe.

    1 Including the sales activities from practitioners, users and distributors

  • PRESS FILE Paris - January 2012

    IMCAS PRESS OFFICE - P.B Communication 7 Villa des Sablons 92200 Neuilly sur Seine - Tel : + 33 1 47 31 11 06 - E-mail : pbcom@wanadoo.fr

    www.imcas.com

    5

    The United States and Latin America will know a growth of about 11%. The North America market will still represent 45% of the global market.

    The annual growth of the market between 2012 and 2016 should be of 11,2%, reaching 5,4 to 6,4 Billions .

    Regarding the different market segments, the injectable products (toxins and fillers) are still the first market segment in value, and will keep on growing for an average of +10% per year through 2016, confirming their development potential for many years. The energy-based devices (laser, radiofrequence, ultrasounds) will catch up with the decrease in business due to 2008-2009 financial crisis, with a average annual growth of 13.2 % through 2016. The cosmeceutics (active cosmetics), new market segment analysis within the Tribune 2012, will follow the same trends than the injectable products. The breast implants will know a reduced progression, estimated to 5,7% through 2016, fitting the progressions observed those last years. Possibly subjected to an impact of the PIP affair, the market could evolve in a less favourable way, especially in Europe. The market segments are, sorted out by decreasing order of importance, are the following ones: (area sorted out by decreasing order)

    1. Injectable products (Toxins and fillers) a. From 1,22-1,47 Billions Euros in 2011, projected to 2,04-2,46 Billions Euros to 2016 b. Average annual growth 2011-2016: +11,1% c. Main areas: USA, EU, Asia, South America.

    2. Energy based devices

    a. From 837-981 Billions Euros in 2011, projected to 1,63-1,91 Billions Euros for 2016 b. Average annual growth 2011-2016: +13,2% c. Main areas: USA, EU and Asia2, South America.

    3. Breast prosthetic implants:

    a. From 637-774 Billions Euros in 2011, projected to 855-1 039 Billions Euros for 2016 b. Average annual growth 2011-2016: +5,7% c. Main areas: USA, Latin America, EU, Asia.

    4. Cosmeceutics (active cosmetic)

    a. From 515-567 Billions Euros in 2011, projected to 887-973 Billions Euros for 2016, b. Average annual growth 2011-2016: +11,1% c. Main areas: USA, Asia, Latin America, EU.